The latest update of “Global Dry Age-Related Macular Degeneration Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Dry Age-Related Macular Degeneration Market.
Overview of the Dry Age-Related Macular Degeneration Market:
The early stage of dry age-related macular degeneration is characterized by very little visual impairment. The disease is caused by abnormalities in the macula that have pigmentary origins. This condition is usually detected through a comprehensive eye examination and regular follow-up exams every one to two years. The dry form of age-related macular degeneration usually progresses to the wet form, which is characterized by the presence of abnormal blood vessels underneath the macula. This leakage damages the macula and makes central vision blurry.
Market Drivers:
Increasing old age population, increase in the prevalence of age-related macular degeneration is expected to fuel growth of the global dry age-related macular degeneration market during the forecast period. According to the National Center of Biotechnology Information (NCBI), the number of people suffering from age-related macular degeneration in EU is estimated to increase from 67-77 million by 2050 and the prevalence of late AMD is expected to increase to 700 000 per year from 400 000 per year in 2050. Moreover, factors such as launch of new treatment methods for dry AMD and rise in the number of clinical trials focusing on dry AMD are also expected to boost growth of the global dry age-related macular degeneration market during the forecast period.
Market Restraints:
High cost of drugs for AMD and unfavorable reimbursement policies as well as insurance coverage for these drugs is expected to hamper growth of the global dry age-related macular degeneration market during the forecast period.
Regional Insights:
North America is expected to witness significant growth in the global dry age-related macular degeneration market during the forecast period due to increasing prevalence of dry AMD, growing cases of diabetes and ophthalmologic conditions. Furthermore, Asia Pacific is also expected to witness robust growth in the global dry age-related macular degeneration market, owing to rise in the number of cases of eye disorders, growing healthcare spending across the regions.
Competitive Section:
Major players operating in the global dry age-related macular degeneration market are Stealth Biotherapeutics Inc., Santen Pharmaceuticals Inc., Yuyang DNU Co., Ltd, Allergan plc., Yuyang DNU Co., Ltd, Bausch Health, Eyestem Research Pvt Ltd, Alimera Science Inc., Iveric Bio, Phio Pharmaceuticals Corp, Kubota Vision Inc., Ocumension Therapeutics Co. Ltd, and Belite Bio Inc.
In June 2020, Belite Bio, a clinical-stage biotechnology company announced positive results from two Phase 1 clinical trial in the U.S. and Australia for a first oral small molecule RBP4 (retinol-binding protein 4) particular antagonist focused on treating dry AMD.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Dry Age-Related Macular Degeneration Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Dry Age-Related Macular Degeneration Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Santen Pharmaceuticals Inc. (Japan)
- Allergan plc (Ireland)
- Bausch Health (Canada)
- Alimera Science Inc. (US)
- Phio Pharmaceuticals Corp (US)
- Ocumension Therapeutics Co. Ltd (China)
- Belite Bio Inc. (US)
- Kubota Vision Inc. (US)
- Iveric Bio (US)
- Eyestem Research Pvt Ltd (India)
- Yuyang DNU Co., Ltd (South Korea)
- Stealth Biotherapeutics Inc. (US)
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Dry Age-Related Macular Degeneration Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Early AMD
- Intermediate AMD
- Late AMD
By Applications, the market is segmented into:
- Treatment
- Nutrition Therapy
- Antioxidants
- Vitamins
- Zinc
- Copper
- Omega-3 fatty acids
- Others
- Telescopic Lens Implant
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dry Age-Related Macular Degeneration Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Dry Age-Related Macular Degeneration Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Dry Age-Related Macular Degeneration Market
1.6.1 How the Covid-19 is Affecting the Dry Age-Related Macular Degeneration Market
1.6.1.1 Dry Age-Related Macular Degeneration Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Dry Age-Related Macular Degeneration Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Dry Age-Related Macular Degeneration Market Perspective (2015-2028)
2.2 Dry Age-Related Macular Degeneration Market Growth Trends by Regions
2.2.1 Dry Age-Related Macular Degeneration Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Dry Age-Related Macular Degeneration Market Historic Market Share by Regions (2015-2021)
2.2.3 Dry Age-Related Macular Degeneration Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Dry Age-Related Macular Degeneration Market Growth Strategy
2.3.6 Primary Interviews with Key Dry Age-Related Macular Degeneration Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dry Age-Related Macular Degeneration Market Players by Market Size
3.1.1 Global Top Dry Age-Related Macular Degeneration Market Players by Revenue (2015-2021)
3.1.2 Global Dry Age-Related Macular Degeneration Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dry Age-Related Macular Degeneration Market Concentration Ratio
3.2.1 Global Dry Age-Related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dry Age-Related Macular Degeneration Market Revenue in 2019
3.3 Dry Age-Related Macular Degeneration Market Key Players Head office and Area Served
3.4 Key Players Dry Age-Related Macular Degeneration Market Product Solution and Service
3.5 Date of entering into Dry Age-Related Macular Degeneration Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Dry Age-Related Macular Degeneration Market Historic Market Size by Type (2015-2021)
4.2 Global Dry Age-Related Macular Degeneration Market Forecasted Market Size by Type (2021-2028)
5 Dry Age-Related Macular Degeneration Market Breakdown Data by Application (2015-2028)
5.1 Global Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
5.2 Global Dry Age-Related Macular Degeneration Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Dry Age-Related Macular Degeneration Market Size (2015-2021)
6.2 Dry Age-Related Macular Degeneration Market Key Players in North America (2019-2021)
6.3 North America Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
6.4 North America Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
7 Europe
7.1 Europe Dry Age-Related Macular Degeneration Market Size (2015-2021)
7.2 Dry Age-Related Macular Degeneration Market Key Players in Europe (2019-2021)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
7.4 Europe Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
8 China
8.1 China Dry Age-Related Macular Degeneration Market Size (2015-2021)
8.2 Dry Age-Related Macular Degeneration Market Key Players in China (2019-2021)
8.3 China Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
8.4 China Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
9 Japan
9.1 Japan Dry Age-Related Macular Degeneration Market Size (2015-2021)
9.2 Dry Age-Related Macular Degeneration Market Key Players in Japan (2019-2021)
9.3 Japan Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
9.4 Japan Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Dry Age-Related Macular Degeneration Market Size (2015-2021)
10.2 Dry Age-Related Macular Degeneration Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
10.4 Southeast Asia Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
11 India
11.1 India Dry Age-Related Macular Degeneration Market Size (2015-2021)
11.2 Dry Age-Related Macular Degeneration Market Key Players in India (2019-2021)
11.3 India Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
11.4 India Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Dry Age-Related Macular Degeneration Market Size (2015-2021)
12.2 Dry Age-Related Macular Degeneration Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Dry Age-Related Macular Degeneration Market Size by Type (2015-2021)
12.4 Central & South America Dry Age-Related Macular Degeneration Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Dry Age-Related Macular Degeneration Market Introduction
13.4 Dry Age-Related Macular Degeneration Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Dry Age-Related Macular Degeneration Market Key Market Segments
Table 2. Key Players Covered: Ranking by Dry Age-Related Macular Degeneration Market Revenue
Table 3. Ranking of Global Top Dry Age-Related Macular Degeneration Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Dry Age-Related Macular Degeneration Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Dry Age-Related Macular Degeneration Market Players to Combat Covid-19 Impact
Table 10. Global Dry Age-Related Macular Degeneration Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Dry Age-Related Macular Degeneration Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Dry Age-Related Macular Degeneration Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Dry Age-Related Macular Degeneration Market Share by Regions (2015-2021)
Table 14. Global Dry Age-Related Macular Degeneration Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Dry Age-Related Macular Degeneration Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Dry Age-Related Macular Degeneration Market Growth Strategy
Table 20. Main Points Interviewed from Key Dry Age-Related Macular Degeneration Market Players
Table 21. Global Dry Age-Related Macular Degeneration Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Dry Age-Related Macular Degeneration Market Share by Players (2015-2021)
Table 23. Global Top Dry Age-Related Macular Degeneration Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Age-Related Macular Degeneration Market as of 2019)
Table 24. Global Dry Age-Related Macular Degeneration Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Dry Age-Related Macular Degeneration Market Product Solution and Service
Table 27. Date of entering into Dry Age-Related Macular Degeneration Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 30. Global Dry Age-Related Macular Degeneration Market Size Share by Type (2015-2021)
Table 31. Global Dry Age-Related Macular Degeneration Market Revenue Market Share by Type (2021-2028)
Table 31. Global Dry Age-Related Macular Degeneration Market Size Share by Application (2015-2021)
Table 33. Global Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 34. Global Dry Age-Related Macular Degeneration Market Size Share by Application (2021-2028)
Table 35. North America Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 37. North America Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 38. North America Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 39. North America Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 40. North America Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 41. Europe Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 43. Europe Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 45. Europe Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 47. China Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 49. China Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 50. China Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 51. China Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 52. China Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 53. Japan Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 55. Japan Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 57. Japan Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 61. Southeast Asia Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 63. Southeast Asia Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 65. India Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 67. India Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 68. India Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 69. India Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 70. India Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Dry Age-Related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Dry Age-Related Macular Degeneration Market Share (2019-2021)
Table 73. Central & South America Dry Age-Related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Dry Age-Related Macular Degeneration Market Share by Type (2015-2021)
Table 75. Central & South America Dry Age-Related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Dry Age-Related Macular Degeneration Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Dry Age-Related Macular Degeneration Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Dry Age-Related Macular Degeneration Market Share by Type: 2021 VS 2028
Figure 2. Global Dry Age-Related Macular Degeneration Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Dry Age-Related Macular Degeneration Market Report Years Considered
Figure 8. Global Dry Age-Related Macular Degeneration Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Dry Age-Related Macular Degeneration Market Share by Regions: 2021 VS 2028
Figure 10. Global Dry Age-Related Macular Degeneration Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Dry Age-Related Macular Degeneration Market Share by Players in 2019
Figure 13. Global Top Dry Age-Related Macular Degeneration Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Dry Age-Related Macular Degeneration Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Dry Age-Related Macular Degeneration Market Revenue in 2019
Figure 15. North America Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Dry Age-Related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
